Scientists from Yale University have published a study that demonstrates how a part of the brain that plays a significant role in the sensation of pain can be suppressed by non-psychoactive parts of the cannabis plant. Cannabidiol (CBD), cannabigerol (CBG), and cannabinol (CBN) are non-psychoactive cannabinoids [...]
A recent YouGov poll, asking the British public their views on cannabis reform compared to those held by politicians, has shown that a majority of both groups support some sort of cannabis reform. The survey, conducted between 8th and 9th January 2025, asked members of the [...]
Canadian researchers have developed a unique method to allow for standardized cannabis dosing among different consumption methods. Researchers at UBC Okanagan have created an Index of Cannabis Equivalence (ICE), a unique approach to standardized cannabis dosing across different consumption methods. Published in the Journal of Psychoactive [...]
Researchers have published a study which shows a correlation between cannabis use and an increase in the amount of daily exercise a person carries out. Uptakes in people’s cigarette and alcohol use were also linked to cannabis use. The data was taken from a nationwide survey [...]
The Czech Republic is continuing to make progress on an ambitious overhaul of its drug policies, with sweeping reforms aimed at creating a regulated market for low-risk psychoactive substances and addressing long-standing issues in medical cannabis access. Starting July 2025, the sale of low-THC cannabis and [...]
Ross Ulbricht, the founder of the darknet marketplace Silk Road, has been granted a presidential pardon by Donald Trump on the first day of his second term as President of the United States. Ulbricht, who was sentenced to a whole life sentence in 2015, was released [...]
UK brand, HEMPE, has secured NSF certification for its CBD gel, giving it the green-light for use among professional athletes and military personnel. The Dorset-based brand was founded by former boyband star and commando, Farard Darver, following an injury in Afghanistan. HEMPE’S CBD gel is now [...]
The airline Jet2 has apologised to a medical cannabis patient—and is said to be ‘reviewing its policies’—after their medication was confiscated on a flight from Belfast. David Toms from Belfast, who is prescribed cannabis-based medicines for chronic pain and anxiety, was flying to Antalya in Turkey [...]
Professor Terry O’Brien and his team have taken a slick approach to battling hard-to-treat epilepsy with a groundbreaking transdermal cannabidiol (CBD) gel. Here’s the scoop: After 6 months of this skin-applied magic, over half the trial participants saw their seizures sliced by more than 50%! Let’s rewind. In 2018, the U.S. FDA gave a thumbs-up to a cannabidiol […]
The post World First Australian & New Zealand Trial of Cannabidiol Transdermal Gel For Hard-to-Treat Epilepsy appeared first on I Am Billy.
Nearly 1 million Americans (many 45 and older) are battling the muscle spasms and pain that come with multiple sclerosis (MS). Turns out, up to 66% of them might be giving medical cannabis a whirl, according to a 2017 survey. And guess what? Many are dialing down on their traditional pharmaceutical MS meds. Fun fact: […]
The post How Prescription Cannabis is Shaping Up The Fight against Multiple Sclerosis appeared first on I Am Billy.
Feeling frazzled, down, or haunted by the past? Turns out, prescription cannabis might just be the unconventional companion for your mind’s rollercoaster. A recent survey found 1 in 5 older adults turning to prescription cannabis to zap the blues and calm the chaos – and over 90% claimed it worked like magic! When it comes […]
The post Prescription Cannabis: Superhero or Supervillain in Treatment of Mental Health? appeared first on I Am Billy.
Over 600,000 Americans are turning to cannabis to kiss chronic pain goodbye and science is totally backing them up. Gold-standard clinical trials (the real deal) have shown cannabis can cut pain by a whopping 40 percent for folks grappling with serious health curveballs like nerve pain (hello, diabetes), spinal cord injuries, HIV, complex regional pain […]
The post Can Prescription Cannabis Help Tame Chronic Pain? appeared first on I Am Billy.
A team of researchers from University College London (UCL) have begun a clinical trial exploring the potential of DMT to treat alcohol use disorder. The study aims to enhance treatment options for individuals seeking to reduce or eliminate their alcohol consumption, and “to better understand how [...]
The UK Government is being sued by a CBD business for £3.4m, in the latest major challenge to its mishandling of legal hemp. Ocean Development (Dorset) Ltd. and connected retail business CBD Flower Shop Ltd. are seeking damages from the Home Office amid allegations of ‘unlawful [...]
Wynk, a leading brand in hemp-derived THC-infused beverages, is expanding into Florida, marking an exciting milestone in its growth across the Southeast. After successful launches in Texas and Georgia, Wynk is thrilled to introduce its light, social THC seltzers to Floridians. From Jacksonville to Miami, Wynk [...]
Scientists from the University of Kentucky (UK) are set to embark on a ground-breaking study which will explore the benefits of administering cannabis-based medicines to patients living with late-stage dementia. Care providers are restricted by the small number of treatment options available for controlling the symptoms [...]
Medical cannabis patients in the UK who receive social care packages from their local authority can apply to have their cannabis-based prescription medicines (CBPM) costs assessed as Disability Related Expenditure (DRE). If accepted, this may reduce the costs of their social care charges but does not cover costs of the cannabis prescription. Understanding Social Care Charges Under Section 14 of the Care Act 2014, local authorities can charge for social care, but they must ensure that such charges are fair and transparent. A financial assessment will determine what an individual can afford, factoring in: The assessment will disregard: Claiming CBPM Costs as DRE Patients can request that their CBPM prescription costs be considered DRE. While many councils have predefined checklists of eligible expenses, additional items may also be considered if supported by evidence. Local authorities must follow the Care Act 2014 principles, which include promoting individual wellbeing, social inclusion, and independence. If prescription costs are not accepted as DRE, it could be considered a breach of the Act, especially if this impacts a patient’s wellbeing or independence. Supporting Your Claim To claim CBPM costs as DRE, patients must provide evidence demonstrating: Unfortunately, many councils may not accept evidence from medical cannabis prescribers and instead require support from a GP and/or healthcare consultant. Patients are encouraged to request a supporting letter from their GP or healthcare consultant, detailing the necessity of CBPM and its role in reducing other treatments, such as opioids. If Your Claim Is Denied If a local authority rejects your request to classify CBPM costs as DRE, you can: The Ombudsman can recommend remedies for councils to implement. While their recommendations are not legally binding, councils rarely refuse to comply. Ensure that all medical evidence is shared with the Council and the Ombudsman. Example Case In a recent case (LGSCO reference: 24 001 331), Brighton & Hove City Council was found at fault for mishandling a social care assessment. Patients can use such precedents to support their claims. In the recent review by the Local Government and Social Care Ombudsman (LGSCO), significant concerns were raised regarding how a council handled a patient’s request to include medical cannabis costs as Disability Related Expenditure (DRE): Implications This case highlights the importance of councils adhering to their legal duty to consider all relevant evidence and provide transparent justifications for their decisions. Patients who encounter similar challenges are encouraged to challenge such decisions through formal complaints and escalate them to the Ombudsman if necessary. Key Takeaways For further guidance: Local Government and Social Care Ombudsman: https://www.lgo.org.uk/ Care Act Statutory Guidance: https://www.gov.uk/government/publications/care-act-statutory-guidance/care-and-support-statutory-guidance Medical Cannabis as Disability Related Expenditure Social Care Case Playlist by Cannabis is Medicine UK: https://www.youtube.com/playlist?list=PLmL0L5mPiFAUwDl6bG51wPOu-53MGGQMo By understanding the process and advocating for your rights, you can ensure fair consideration of your medical cannabis prescription costs within your social care assessment.
The post Claiming Social Care Support for Medical Cannabis Patients in the UK first appeared on PatientsCann UK.
Hundreds of families in the UK are giving their children illegal cannabis products due to a lack of access on the NHS, according to a new report. The research, commissioned by charity Medan Family Foundation, reveals almost 400 families are sourcing illegal cannabis products from drug [...]
Cheba Hut is teaming up with the Last Prisoner Project (LPP) for the fourth consecutive SmokeOut Injustice day. It’s all about turning tasty meals into real change and raising funds to support cannabis criminal justice reform. Last year, the team at Cheba Hut raised $133,872 for [...]
The first medical cannabis products have officially been registered in Ukraine, meaning patients should be able to access treatment in the coming weeks. Curaleaf International has successfully registered three separate oil-based products in the country, which legalised medical cannabis last August. While it will be the first [...]
Meet our main character: a 33-year-old guy who got slapped with an unexpected ADHD diagnosis later in life. His first treatment? Good old Ritalin. Things started off fine – until they didn’t. After some nasty side effects and a merry-go-round of alternative meds, our patient stumbled upon something a bit more… natural. Enter prescription cannabis. […]
The post A Dive into Medical Cannabis for Adult ADHD – A Sociological Case Report appeared first on I Am Billy.
Chronic pain – that nagging discomfort that sticks around for at least three months like an unwelcome houseguest. 40 prescription cannabis users V 161 opioid users Both opioids and prescription cannabis are the go-to contenders for pain relief. Opioids are like the heavyweight champs – quick and effective at knocking out pain, whether it’s […]
The post Prescription Cannabis V Opioids in Chronic Pain – Who’s Got the Holistic Edge? appeared first on I Am Billy.
A new study has investigated changes in opioid use in US states which have passed medical and recreational cannabis laws. The study, led by Columbia University Mailman School of Public Health, found no changes in opioid outcomes among the general population following the states’ passage of [...]
A study has found that the structural difference in the brains of people who use drugs may be present before experimentation with substances, casting doubt on the contested gateway theory that soft drug experimentation leads to harder drug use. Scientists studied the brains of nearly 10,000 [...]
At PatientsCann UK, we are deeply concerned by Network Rail’s recently issued safety advice (NRA24-13), which imposes a blanket ban
The post Network Rail’s Medical Cannabis Policy: A Cause for Concern first appeared on PatientsCann UK.
A trial went down at the San Carlo Hospital’s pain therapy unit in Potenza, Italy, using prescription cannabis in patients with fibromyalgia. The Scoop; Patients with fibromyalgia saw their pain intensity (on the trusty NRS scale) nosedive from an eye-watering 8 to a manageable 4 over just 6 months. Things didn’t just stop at pain […]
The post Can Prescription Cannabis Help Tame Fibro Pain? appeared first on I Am Billy.
Smoking a single cigarette can take around 20 minutes off a person’s life, according to research commissioned by the Department of Health. In a report, published in the journal Addiction, researchers at University College London found that the average loss of life per cigarette smoked was [...]
The authors of a new Canadian study have called for increased public funding to protect the ‘scientific integrity’ of cannabis research and reduce reliance on industry sponsorship. Research led by the Centre for Addiction and Mental Health (CAMH) in Canada, sheds light on the ethical complexities [...]
Inflammatory bowel disease (IBD) patients in the UK have reported improvements in their condition following treatment with medical cannabis. According to observational data published in the journal Expert Review of Gastroenterology & Hepatology, medical cannabis treatment was associated with sustained improvements in health-related quality of life [...]
New preliminary research highlights the potential of Ayurvedic medicine combined with medical cannabis as an alternative treatment for menstrual cramps. Results from a Phase 1 clinical trial have found ‘strong preliminary evidence’ to support the safety and efficacy of a new patent-pending formulation in the management [...]
A single 800mg dose of orally administered CBD can significantly reduce a subject’s cravings for alcohol, according to the results of a new study. Researchers from the Department of Addictive Behavior and Addiction Medicine at the University of Heidelberg in Germany analysed how CBD impacts alcohol [...]
Thousands of French medical cannabis patients have been given a temporary reprieve, enabling them to continue accessing their treatment for another six months. Amid the continued political chaos in the country, participants in France’s medical cannabis ‘experiment,’ which is now entering its fifth year, faced an [...]
A new study has revealed that deaths caused by opioid overdose in the USA go down directly after the legalisation of recreational cannabis. The study also showed that states which changed their cannabis legislation earlier experienced an even greater decrease in deaths than others that did [...]
Data taken from the UK Medical Cannabis Registry has shown a positive association between cannabis and improved health-related quality of life for people who have been diagnosed with inflammatory bowel disease (IBD). IBD is an umbrella term for conditions that affect the stomach. Symptoms can range [...]
Copyright © 2020 – 2026 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.
